Trials / Completed
CompletedNCT03884374
Pain Relief for OsteoArthritis Through Combined Treatment (PROACT)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 317 (actual)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 45 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This mechanistic clinical trial proposes to test whether a five-day course of mindfulness meditation training (MMT) and tDCS, and their combination, can enhance pain modulatory balance and pain-related brain function, reduce clinical pain, among African Americans and non-Hispanic whites with knee osteoarthritis (OA). This approach will provide evidence that targeting stress and pain-related brain function will reduce OA-related pain and ethnic group differences therein.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Focused Breathing and Attention Training (BAT) | Participants will receive mindfulness-based mental training regimen to independently practice mindfulness meditation. |
| BEHAVIORAL | Standard Breathing and Attention Training (BAT) | Standard BAT intervention will incorporate most of the general aspects of the Focused BAT intervention but without the specific instructions related to mindfully attending to the breath in a non-evaluative manner. |
| DEVICE | Transcranial Direct Current Stimulation (tDCS) | A Soterix 1x1 Clinical Trials Direct Current Stimulator will apply 20 minutes of 2.0mA direct current through two bicarbon rubber electrodes encased in saline-soaked sponges |
| DEVICE | Sham Transcranial Direct Current Stimulation (tDCS) | Sham stimulation procedures will be identical except for the duration of stimulation. Participants will receive 30 seconds of 2 mA (30s ramp up/down) of stimulation at the beginning of the session. |
Timeline
- Start date
- 2020-03-13
- Primary completion
- 2025-02-28
- Completion
- 2025-02-28
- First posted
- 2019-03-21
- Last updated
- 2025-08-15
- Results posted
- 2025-08-15
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03884374. Inclusion in this directory is not an endorsement.